PMD 2.3 (+0%)
US7443752057Medical Diagnostics & ResearchDiagnostics & Research

Psychemedics (PMD) Competitor Comparison

We are evaluating the key criteria listed to compare Psychemedics (PMD) against its competitors in the Diagnostics & Research industry.

Performance 10 years - PMD ranking 47 / 58

These are the competitors of Psychemedics in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.56K
3. Medpace Holdings MEDP
952.5
4. Natera NTRA
722.67
5. RadNet RDNT
458.07
6. IDEXX Laboratories IDXX
445.34
7. DexCom DXCM
307.67
8. PerkinElmer PKI
247.07
9. CareDx CDNA
233.71
10. Danaher DHR
228
11. Thermo Fisher Scientific TMO
224.33
12. Mettler-Toledo MTD
209.91
13. Twist Bioscience TWST
183.08
14. Waters WAT
158.67
15. Agilent Technologies A
139.78
16. Quest Diagnostics DGX
117.07
17. IQVIA Holdings IQV
114.95
18. Syneos Health SYNH
113.83
19. Icon ICLR
103.39
20. Laboratory Corp of America Holdings LH
102.46
21. NeoGenomics NEO
98.54
22. Fulgent Genetics FLGT
93.92
23. Exact Sciences EXAS
73.97
24. Guardant Health GH
62.05
25. Meridian Bioscience VIVO
60.69
26. Qiagen QGEN
55.22
27. Charles River Laboratories CRL
36.08
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Anixa Biosciences ANIX
-16.31
30. Inotiv NOTV
-21.15
31. National Research NRC
-24.06
32. Olink Holding OLK
-26.82
33. Bioventus BVS
-48.21
34. Sotera Health SHC
-61.19
35. Illumina ILMN
-61.7
36. Global Cord Blood CO
-66.57
37. Exagen XGN
-73.27
38. Neogen NEOG
-75.07
39. DarioHealth DRIO
-75.47
40. Sera Prognostics SERA
-77.35
41. Enzo Biochem ENZ
-77.8
42. Myriad Genetics MYGN
-78.41
43. Pacific Biosciences of California PACB
-81.66
44. Co-Diagnostics CODX
-83.5
45. MaxCyte MXCT
-84.64
46. Personalis PSNL
-86.48
47. Psychemedics PMD
-86.55
48. MDxHealth MDXH
-86.83
49. bioAffinity Technologies BIAF
-88.45
50. Biodesix BDSX
-92.64
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.65
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.9
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.49
58. Precipio PRPO
-99.77

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.